sharon sanders
Editor-in-Chief & President
- Letter
- Published: 18 June 2020
- Quan-Xin Long,
- Xiao-Jun Tang,
- Qiu-Lin Shi,
- Qin Li,
- Hai-Jun Deng,
- Jun Yuan,
- Jie-Li Hu,
- Wei Xu,
- Yong Zhang,
- Fa-Jin Lv,
- Kun Su,
- Fan Zhang,
- Jiang Gong,
- Bo Wu,
- Xia-Mao Liu,
- Jin-Jing Li,
- Jing-Fu Qiu,
- Juan Chen &
- Ai-Long Huang
- 2423 Altmetric
- Metricsdetails
The clinical features and immune responses of asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been well described. We studied 37 asymptomatic individuals in the Wanzhou District who were diagnosed with RT–PCR-confirmed SARS-CoV-2 infections but without any relevant clinical symptoms in the preceding 14 d and during hospitalization. Asymptomatic individuals were admitted to the government-designated Wanzhou People’s Hospital for centralized isolation in accordance with policy[SUP]1[/SUP]. The median duration of viral shedding in the asymptomatic group was 19 d (interquartile range (IQR), 15–26 d). The asymptomatic group had a significantly longer duration of viral shedding than the symptomatic group (log-rank P = 0.028). The virus-specific IgG levels in the asymptomatic group (median S/CO, 3.4; IQR, 1.6–10.7) were significantly lower (P = 0.005) relative to the symptomatic group (median S/CO, 20.5; IQR, 5.8–38.2) in the acute phase. Of asymptomatic individuals, 93.3% (28/30) and 81.1% (30/37) had reduction in IgG and neutralizing antibody levels, respectively, during the early convalescent phase, as compared to 96.8% (30/31) and 62.2% (23/37) of symptomatic patients.
Forty percent of asymptomatic individuals became seronegative and 12.9% of the symptomatic group became negative for IgG in the early convalescent phase. In addition, asymptomatic individuals exhibited lower levels of 18 pro- and anti-inflammatory cytokines. These data suggest that asymptomatic individuals had a weaker immune response to SARS-CoV-2 infection. The reduction in IgG and neutralizing antibody levels in the early convalescent phase might have implications for immunity strategy and serological surveys.
https://www.nature.com/articles/s41591-020-0965-6